Premium
The best of De Telegraaf
–
Door Paul Demeyer
in INTERIOR
—
–
Ⓒ ANP / HH / ROBIN UTRECHT
—
BRUSSELS – Pharmaceutical Pfizer is working hard to adapt its vaccine so that it is also resistant to the omicron variant. But that takes a lot of work. In the meantime, the new variant continues to be frantically around the world. That is what the Belgian virologist Marc Van Ranst and professor Geert Molenberghs say in conversation with The newspapaer.
–
Related posts:
The latest rendering of the iPhone 15 bender is exposed! Equipped with dual screens, flagship lens, ...
Pipe Connections Competitive Insights into the Market and Precise Outlook 2020-2029 | Victaulic, Pi...
UN Human Rights Council Adopts Resolution Condemning Coup In Myanmar
strong winds cause damage to SoCal; Possible electrical interruptions by thanking